EXPLORING ENVIRONMENTAL IMPACTS OF SWITCHING SALMETEROL/FLUTICASONE PROPIONATE (SAL/FP) FROM METERED DOSE INHALER (MDI) TO DRY POWDER INHALER (DPI) IN RESPIRATORY ILLNESS IN THE UNITED KINGDOM

被引：0

作者：

Siddiqui, A. H. ^{[1
]}

Hughes, R. ^{[1
]}

Brandolini, G. ^{[1
]}

Hirst, A. ^{[2
]}

机构：

[1] Adelphi Values PROVE, Bollington, Cheshire, England

[2] Adelphi Values PROVE, Bollington, CHW, England

来源：

VALUE IN HEALTH | 2024年 / 27卷 / 06期

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

EE311

引用

页码：S114 / S114

页数：1

共 48 条

[21] Assessment of the efficacy and safety of fluticasone propionate and salmeterol delivered as a combination dry powder via a capsule-based inhaler and a multi-dose inhaler in patients with asthma
Chan, Robert
Sousa, Ana R.
Mallett, Stephen
Hynds, Peter
Homayoun-Valiani, Farshid
Tabberer, Maggie
Mehta, Rashmi
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2016, 41 : 19 - 24
[22] Comparison of the Pharmacokinetics of Salmeterol and Fluticasone Propionate 50/100 µg Delivered in Combination as a Dry Powder Via a Capsule-Based Inhaler and a Multi-Dose Inhaler
Rashmi Mehta
Kylie Riddell
Ashutosh Gupta
Margaret D Louey
Robert H. Chan
Clinical Drug Investigation, 2015, 35 : 319 - 326
[23] Effect of Inhalation Patterns on the Delivered Dose of SymbicortT from a Dry Powder Inhaler Compared to a Metered Dose Inhaler (MDI) Plus Valved Holding Chamber (VHC)
Nagel, M.
Ali, R.
Suggett, J.
Doyle, C.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
[24] Peak inhalation rates (PIFRs) of COPD patients when using a metered dose inhaler (MDI) and recently introduced dry powder inhalers (DPI)
Tarsin, W
Alshowair, RAM
Corrado, OJ
Pearson, SB
Chrystyn, H
THORAX, 2003, 58 : 73 - 73
[25] Equivalence Of Fluticasone Propionate/salmeterol Delivered Via New Multi-Dose Dry Powder Inhaler And Accuhaler™ In Adolescent And Adult Asthma
Kuna, P.
Gath, I.
Thyroff-Friesinger, U.
Jones, S.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
[26] Effects of switching from a metered dose inhaler to a dry powder inhaler on climate emissions and asthma control: post-hoc analysis
Woodcock, Ashley
Janson, Christer
Rees, Jamie
Frith, Lucy
Lofdahl, Magnus
Moore, Alison
Hedberg, Martin
Leather, David
THORAX, 2022, 77 (12) : 1187 - 1192
[27] Effect of Adjustable-Dose (AD) Budesonide/Formoterol Pressurized Metered-Dose Inhaler (pMDI), Fixed-Dose (FD) Budesonide/Formoterol pMDI, and FD Fluticasone/Salmeterol Dry Powder Inhaler (DPI) on Predose FEF25-75%.
Kim, K. T.
Lanier, B. Q.
Goldman, M.
Martin, P.
Zangrilli, J.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
[28] Comparison of Patient-Reported Outcomes During Treatment With Adjustable- and Fixed-Dose Budesonide/Formoterol Pressurized Metered-Dose Inhaler Versus Fixed-Dose Fluticasone Propionate/Salmeterol Dry Powder Inhaler in Patients With Asthma
O'Connor, Richard D.
Patrick, Donald L.
Parasuraman, Bhash
Martin, Paula
Goldman, Mitchell
JOURNAL OF ASTHMA, 2010, 47 (02) : 217 - 223
[29] Clinical equivalence of salmeterol/fluticasone propionate in combination (50/100 μg twice daily) when administered via a chlorofluorocarbon-free metered dose inhaler or dry powder inhaler to patients with mild-to-moderate asthma
Bateman, ED
Silins, V
Bogolubov, M
RESPIRATORY MEDICINE, 2001, 95 (02) : 136 - 146
[30] Safety of albuterol sulfate (AS) via spiros™ dry powder inhaler (DPI) compared to albuterol (A) via ventolin™ metered dose inhaler (MDI) and to placebo over 12 weeks in patients with asthma.
Kemp, J
Nelson, H
Bieler, S
Vaughan, L
Hill, M
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 101 (01) : S7 - S7

← 1 2 3 4 5 →